Artificial intelligence is a powerful tool for rare disease drug discovery. The founders of Vesalius Therapeutics say AI and machine learning can also be applied to common diseases, and the startup has launched with $75 million in committed financing.
ViVE 2022, powered by HLTH and CHIME, will convene top thought leaders who are shaping tech-enabled healthcare and addressing key issues in digital health innovation. Save $150 with code medcity150!
In the U.S., EndeavorRx has been cleared to help in improving attention function as measured by computer-based testing in children ages 8-12 years who have primarily inattentive or combined-type ADHD who struggle with maintaining attention.
Falls are the No. 1 cause of nonfatal emergency room visits, costing tens of billions annually, and one the top five Medicare expenditures. But many healthcare plans are performing poorly in fall prevention.
Simple-to-use integrated scheduling and two-way engagement are critical in equipping healthcare providers to deliver a better patient experience in the digital future.
By Michael Schroeder Wednesday, March 2, 2022 4:02 PM
The care plans, available through the company's app, draw on predictive technology to help identify preventive treatments for lower-risk and higher-risk patients alike. Patients are reminded to schedule follow-up appointments, screenings and annual wellness visits, along with adhering to treatment recommendations.
Solv Health launched ClearPrice that compiles data from more than 5,000 providers so consumers can evaluate the cost of various services before they are rendered and decide if they want to pay cash or use insurance.
Artificial intelligence is a powerful tool for rare disease drug discovery. The founders of Vesalius Therapeutics say AI and machine learning can also be applied to common diseases, and the startup has launched with $75 million in committed financing.
No comments